Fertility and Sterility
Volume 93, Issue 4 , Pages 1234-1243 , 1 March 2010

Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses

Presented at the 62d Annual Meeting of the American Society for Reproductive Medicine, which was held in New Orleans, Louisiana, on October 21–25, 2006.

  • Carolyn R. Jaslow, Ph.D.

      Affiliations

    • Department of Biology, Rhodes College, University of Tennessee, Memphis, Tennessee
    • ,
  • Judi L. Carney, M.D.

      Affiliations

    • Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Tennessee
    • ,
  • William H. Kutteh, M.D., Ph.D.

      Affiliations

    • Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Tennessee
    • Fertility Associates of Memphis, Memphis, Tennessee
    • Corresponding Author InformationReprint requests: William H. Kutteh, M.D., Ph.D., Fertility Associates of Memphis, 80 Humphreys Center, No. 307, Memphis, Tennessee 38120 (FAX: 901-747-4446).

Received 18 September 2008 ,Revised 14 January 2009 ,Accepted 30 January 2009.

References 

  1. Stephenson M, Kutteh WH. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50:132–145
  2. Christiansen OB, Nielsen HS, Kolte A, Pedersen AT. Research methodology and epidemiology of relevance in recurrent pregnancy loss. Semin Reprod Med. 2006;24:5–16
  3. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343:1015–1018
  4. George L, Mills JL, Johansson AL, Nordmark A, Olander B, Granath F, et al. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288:1867–1873
  5. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid exposure. JAMA. 2004;292:691–695
  6. Donders GGG, Van Bulck B, Caudron J, Londers L, Vereecken A, Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol. 2000;183:431–437
  7. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216–2222
  8. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66:24–29
  9. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. 1997;12:387–389
  10. Salim R, Regan L, Woelfer B, Backos M, Jurkovic D. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod. 2003;18:162–166
  11. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol. 2004;104:784–788
  12. Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet Gynecol. 1989;96:275–280
  13. Bussen S, Sütterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod. 1999;14:18–20
  14. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. 1998;70:246–252
  15. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami A, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost. 1996;75:387–388
  16. Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348:913–916
  17. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002;77:342–347
  18. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril. 1996;66:540–546
  19. Krabbendam I, Franx A, Bots ML, Fijnheer R, Bruinse HW. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol. 2005;118:143–153
  20. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. Arch Intern Med. 2004;164:558–563
  21. Nelen WLDM, Blom HJ, Steegers EAP, Den Heijer M, Eskes TKAB. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000;74:1196–1199
  22. Mtiraoui N, Zammiti W, Ghazouani L, Jmili Braham N, Saidi S, Finan RR, et al. Methylenetetrahydrofolate reductase C667T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction. 2006;131:395–401
  23. Penta M, Lukic A, Conte MP, Chiarini F, Fioriti D, Longhi C, et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol. 2003;26:329–337
  24. Wassertheil-Smoller S. Biostatistics and epidemiology: a primer for health professionals. New York: Springer Verlag; 1990;
  25. Hook EB, Healy NP, Willey AM. How much difference does chromosome banding make?. Ann Hum Genet. 1989;53:237–242
  26. Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol. 1997;89:549–555
  27. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374–380
  28. Krause M, Sonntag B, Klamroth R, Heinecke A, Scholz C, Langer C, et al. Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study. Thromb Haemost. 2005;93:867–871
  29. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–499
  30. Samra Z, Soffer Y, Pansky M. Prevalence of genital chlamydia and mycoplasma infection in couples attending a male infertility clinic. Eur J Epidemiol. 1994;10:69–73
  31. Shepard MK, Senturia YD. Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function. Fertil Steril. 1977;28:541–548
  32. Biller BMK, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med. 1999;44:1075–1084
  33. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod. 2002;17:446–451
  34. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73:300–304
  35. Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril. 2001;75:678–682
  36. Nybo Andersen A-M, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. Br Med J. 2000;320:1708–1712
  37. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. 1984;148:140–146
  38. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994;9:l328–l332
  39. Harger JH, Archer DF, Marchese SG, Muracca-Clemens M, Garver KL. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol. 1983;62:574–581
  40. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901–908
  41. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod. 1997;56:50–58
  42. Franklin RD, Kutteh WH. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol. 2003;101:455–462
  43. Franklin RD, Kutteh WH. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod. 2002;17:2981–2985
  44. Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril. 2005;83:684–690
  45. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 1999;71:1048–1053
  46. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–1057
  47. Di Simone N, Maggiano N, Caliandro D, Riccardi P, Evangelista A, Carducci B, et al. Homocysteine induces trophoblast cell death with apoptotic features. Biol Reprod. 2003;69:1129–1134
  48. Kirke PN, Mills JL, Molloy AM, Brody LC, O'Leary VB, Daly L, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. Br Med J. 2004;328:1535–1536
  49. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862–877
  50. Callejón G, Mayor-Olea A, Jiménez AJ, Gaitán MJ, Palomares AR, Martínez F, et al. Genotypes of the C677T and A1298C polymorphisms of the MTHFR gene as a cause of human spontaneous embryo loss. Hum Reprod. 2007;22:3249–3254
  51. Gürbüz B, Yalti S, Fiçicioğlu C, Ozden S, Yildirim G, Sayar C. Basal hormone levels in women with recurrent pregnancy loss. Gynecol Endocrinol. 2003;17:317–321
  52. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2008;2:CD003511
  53. Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, Holm JP, et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007;136:656–661
  54. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796–1799
  55. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med. 1998;4:1020–1024
  56. Cnattingius S, Signorello LB, Annerén G, Clausson B, Ekbom A, Ljunger E, et al. Caffeine intake and the risk of first-trimester spontaneous abortion. N Engl J Med. 2000;343:1839–1845
  57. Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med. 1999;340:333–339
  58. Carson SA, Branch DW. Management of recurrent early pregnancy loss. Am Coll Obstet Gynecol Pract Bull. 2001;24:1–12

 C.R.J. has nothing to disclose. J.L.C. has nothing to disclose. W.H.K. has nothing to disclose.

 Supported by a Creative Advance Planning Sabbatical Grant from the Andrew W. Mellon Foundation and by the Frank Ling Research Grant in Obstetrics and Gynecology from the University of Tennessee Health Science Center, Memphis, Tennessee.

PII: S0015-0282(09)00308-2

doi: 10.1016/j.fertnstert.2009.01.166

Fertility and Sterility
Volume 93, Issue 4 , Pages 1234-1243 , 1 March 2010

Article Tools